DISSEMINATED LARGE CELL LYMPHOMA

DISSEMINATED LARGE CELL LYMPHOMA was reported 26 times

DISSEMINATED LARGE CELL LYMPHOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-6 Receptor Antagonist [EPC] 8 0.0001
1 Selective T Cell Costimulation Modulator [EPC] 8 0.0001
2 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
3 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
4 Alkaloid [EPC] 1 0.0000
5 Pyridone [EPC] 1 0.0000
6 Protease Inhibitor [EPC] 1 0.0000
7 Muscle Relaxant [EPC] 1 0.0000
8 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
9 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
10 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
11 Alkylating Drug [EPC] 4 0.0000
12 BCL-2 Inhibitor [EPC] 1 0.0000
13 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
14 Topoisomerase Inhibitor [EPC] 1 0.0000
15 Arteriolar Vasodilator [EPC] 1 0.0000
16 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
17 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
18 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
19 Corticosteroid [EPC] 13 0.0000
20 Aminosalicylate [EPC] 1 0.0000
21 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
22 Tumor Necrosis Factor Blocker [EPC] 8 0.0000
23 Leukocyte Growth Factor [EPC] 1 0.0000
24 Azole Antifungal [EPC] 1 0.0000
25 Interferon beta [EPC] 1 0.0000
26 Opioid Agonist [EPC] 1 0.0000
27 Platinum-based Drug [EPC] 1 0.0000
28 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
29 Vitamin D [EPC] 1 0.0000
30 Vitamin B12 [EPC] 1 0.0000
31 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
32 Vitamin C [EPC] 1 0.0000
33 Kinase Inhibitor [EPC] 1 0.0000
34 Platelet Aggregation Inhibitor [EPC] 1 0.0000
35 Proton Pump Inhibitor [EPC] 1 0.0000
36 Benzodiazepine [EPC] 1 0.0000
37 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000